IL-2 has been shown to expand T effector cells for anti-microbial/anti-cancer immunity, while IL-2 can also induce or grow CD4+ CD25+ Foxp3+ regulatory T cells for immune regulation or tolerance [27,28]. The gene discussed is FOXP3; the disease is cancer.